Account for Clinical Heterogeneity in Assessment of Catheter-based Renal Denervation among Resistant Hypertension Patients: Subgroup Meta-analysis

@inproceedings{Chen2017AccountFC,
  title={Account for Clinical Heterogeneity in Assessment of Catheter-based Renal Denervation among Resistant Hypertension Patients: Subgroup Meta-analysis},
  author={Xiao-Han Chen and Sehee Kim and Xiao-xi Zeng and Zhi-Bing Chen and Tian-lei Cui and Zhang-xue Hu and Yi Li and P. L. Fu},
  booktitle={Chinese medical journal},
  year={2017}
}
BACKGROUND Catheter-based renal denervation (RDN) is a novel treatment for resistant hypertension (RH). A recent meta-analysis reported that RDN did not significantly reduce blood pressure (BP) based on the pooled effects with mild to severe heterogeneity. The aim of the present study was to identify and reduce clinical sources of heterogeneity and reassess the safety and efficacy of RDN within the identified homogeneous subpopulations. METHODS This was a meta-analysis of 9 randomized… CONTINUE READING
1 Citations
23 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Meta‐analysis of randomized controlled trials of renal denervation in treatment‐resistant hypertension

  • FE Fadl Elmula, Y Jin, WY Yang, L Thijs, YC Lu, AC Larstorp
  • Blood Press 2015;24:263‐74
  • 2015
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…